Systemic Thromboembolism and Stroke After Atrial Fibrillation and Atrial Flutter
In a recent study, published in Cureus, lead author Harshith S. Thyagaturu and colleagues examined the differences in risk for systemic thromboembolism (STE) or...
Risks Versus Benefits of Antithrombotic Therapy in Very Elderly Patients With NVAF
Researchers from the Department of Cardiology at the Sun Yat-sen Memorial Hospital of Sun Yat-sen University in Guangzhou, Guangdong Province, China, led by primary...
Prior Treatment Doses in Patients with Stroke After Oral Anticoagulation Therapy
Oral anticoagulation (OAC) therapy is used for stroke prevention in patients with atrial fibrillation (AFib), but does not completely eliminate stroke risk. Danish cardiologists,...
Prognostic Value of Interleukin-6 for Stroke and Mortality in Atrial Fibrillation
In a study, published in the Anatolian Journal of Cardiology, researchers examined the prognostic value of interleukin-6 (IL-6) for mortality and stroke in atrial fibrillation...
Direct Oral Anticoagulants in Patients with Diabetes and Nonvalvular Atrial Fibrillation
Diabetes mellitus (DM) is a common comorbidity in patients with atrial fibrillation (AF) and is associated with an increased frequency of major adverse cardiac...
Active Screening for Atrial Fibrillation to Protect Against Strokes and Other Events
Seeking to answer if screening asymptomatic individuals for atrial fibrillation (AF) could offer meaningful protection against strokes and other clinical outcomes, Steven Steinhubl, MD,...
Final Results from REPRISE III: Long-Term Stroke Risk after TAVR for Severe Aortic Stenosis
A study presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2021 Annual Meeting reported the final five-year results from the REPRISE III randomized trial, which...
